Ethics & Responsibility

We believe that the power of Computational Biology demands an equally powerful ethical framework. Our ESG strategy is integrated directly into our product lifecycle.

Ethical AI Charter

CytosAI adheres to a strict "Human-in-the-Loop" validation protocol for all generative protein models. We do not license our tech for non-therapeutic biological modifications.

Algorithmic TransparencyBias Mitigation

Clinical Safety

LSI Therapeutics maintains a zero-compromise approach to patient safety, exceeding FDA Phase III monitoring requirements by 40% in data granularity.

Sustainability

Carbon Neutral

Operations certified by 2025.

Governance

45%

Board Diversity (Gender & Ethnicity).